Tributary Capital Management LLC increased its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 21.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 396,093 shares of the technology company's stock after purchasing an additional 70,526 shares during the period. Tributary Capital Management LLC owned 1.97% of Simulations Plus worth $11,047,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of SLP. State Street Corp increased its stake in Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company's stock valued at $20,503,000 after buying an additional 28,953 shares during the period. Geode Capital Management LLC raised its holdings in Simulations Plus by 4.4% during the third quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock worth $14,367,000 after purchasing an additional 18,924 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Simulations Plus by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company's stock valued at $20,128,000 after purchasing an additional 37,992 shares in the last quarter. Royce & Associates LP increased its position in Simulations Plus by 28.8% during the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company's stock worth $7,602,000 after purchasing an additional 53,092 shares during the period. Finally, Congress Asset Management Co. raised its stake in shares of Simulations Plus by 22.5% during the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company's stock worth $6,613,000 after buying an additional 37,914 shares in the last quarter. 78.08% of the stock is owned by hedge funds and other institutional investors.
Simulations Plus Price Performance
NASDAQ:SLP traded up $0.28 on Friday, reaching $33.78. The stock had a trading volume of 223,255 shares, compared to its average volume of 275,382. Simulations Plus, Inc. has a 12-month low of $24.00 and a 12-month high of $51.22. The company has a market cap of $678.64 million, a price-to-earnings ratio of 84.45 and a beta of 0.80. The firm's fifty day moving average is $29.95 and its two-hundred day moving average is $32.84.
Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. The firm had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. Simulations Plus's revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.18 earnings per share. As a group, research analysts forecast that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
SLP has been the topic of a number of recent analyst reports. BTIG Research dropped their price objective on Simulations Plus from $60.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, October 24th. Stephens started coverage on Simulations Plus in a report on Friday, November 15th. They issued an "overweight" rating and a $39.00 price target on the stock. KeyCorp lifted their price target on Simulations Plus from $35.00 to $37.00 and gave the stock an "overweight" rating in a research note on Friday. William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. Finally, StockNews.com cut shares of Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Simulations Plus presently has a consensus rating of "Moderate Buy" and an average target price of $49.40.
Get Our Latest Report on Simulations Plus
Insider Activity at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total transaction of $635,200.00. Following the transaction, the director now owns 3,442,584 shares of the company's stock, valued at $109,336,467.84. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 19.40% of the company's stock.
About Simulations Plus
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Further Reading

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.